Eine Zusammenfassung der neuesten Entwicklungen aus 12 Studien zur BTK-Inhibition bei B-Zell-Malignomen, die auf dem EHA2022 vorgestellt wurden.
Welcome to BeiMedPlus
BeiGene's medical website with resources for healthcare professionals and disease information for patients and caregivers.
Please confirm the option below that best describes you so we can direct you to appropriate resources and information.
I am a...
Healthcare Professional
hcp
Patient / Caregiver
patient
BeiGene Employee
employee
I am from...
GLOBAL (ex-US) / EN
/
GLOBAL (ex-US) / EN
pts-en
France / FR
fr
Germany / DE
de
Italy / IT
it
Italy / IT
pts-it
Spain / ES
es
Sweden / SE
se
Switzerland / DE
ch-de
Switzerland / FR
ch-fr
Switzerland / IT
ch-it
United States / EN
us
